These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 33992697)

  • 1. Evidence for synergy between sarcomeres and fibroblasts in an in vitro model of myocardial reverse remodeling.
    Shen S; Sewanan LR; Campbell SG
    J Mol Cell Cardiol; 2021 Sep; 158():11-25. PubMed ID: 33992697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anisotropic engineered heart tissue made from laser-cut decellularized myocardium.
    Schwan J; Kwaczala AT; Ryan TJ; Bartulos O; Ren Y; Sewanan LR; Morris AH; Jacoby DL; Qyang Y; Campbell SG
    Sci Rep; 2016 Aug; 6():32068. PubMed ID: 27572147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased length-dependent activation of human engineered heart tissue after chronic α
    Rupert C; López JE; Cortez-Toledo E; De la Cruz Cabrera O; Chesler NC; Simpson PC; Campbell SG; Baker AJ
    Am J Physiol Heart Circ Physiol; 2023 Mar; 324(3):H293-H304. PubMed ID: 36637971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.
    Hirt MN; Boeddinghaus J; Mitchell A; Schaaf S; Börnchen C; Müller C; Schulz H; Hubner N; Stenzig J; Stoehr A; Neuber C; Eder A; Luther PK; Hansen A; Eschenhagen T
    J Mol Cell Cardiol; 2014 Sep; 74():151-61. PubMed ID: 24852842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mavacamten preserves length-dependent contractility and improves diastolic function in human engineered heart tissue.
    Sewanan LR; Shen S; Campbell SG
    Am J Physiol Heart Circ Physiol; 2021 Mar; 320(3):H1112-H1123. PubMed ID: 33449850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A myosin activator improves actin assembly and sarcomere function of human-induced pluripotent stem cell-derived cardiomyocytes with a troponin T point mutation.
    Broughton KM; Li J; Sarmah E; Warren CM; Lin YH; Henze MP; Sanchez-Freire V; Solaro RJ; Russell B
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H107-17. PubMed ID: 27199119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure.
    Soppa GK; Lee J; Stagg MA; Felkin LE; Barton PJ; Siedlecka U; Youssef S; Yacoub MH; Terracciano CM
    Cardiovasc Res; 2008 Mar; 77(4):695-706. PubMed ID: 18178572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SarcTrack.
    Toepfer CN; Sharma A; Cicconet M; Garfinkel AC; Mücke M; Neyazi M; Willcox JAL; Agarwal R; Schmid M; Rao J; Ewoldt J; Pourquié O; Chopra A; Chen CS; Seidman JG; Seidman CE
    Circ Res; 2019 Apr; 124(8):1172-1183. PubMed ID: 30700234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recapitulating maladaptive, multiscale remodeling of failing myocardium on a chip.
    McCain ML; Sheehy SP; Grosberg A; Goss JA; Parker KK
    Proc Natl Acad Sci U S A; 2013 Jun; 110(24):9770-5. PubMed ID: 23716679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analyses of the inotropic compound omecamtiv mecarbil in rat and human cardiac preparations.
    Rhoden A; Schulze T; Pietsch N; Christ T; Hansen A; Eschenhagen T
    Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H373-H385. PubMed ID: 35030072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-Dependent Effects of the Myosin Activator Omecamtiv Mecarbil on Cross-Bridge Behavior and Force Generation in Failing Human Myocardium.
    Mamidi R; Li J; Gresham KS; Verma S; Doh CY; Li A; Lal S; Dos Remedios CG; Stelzer JE
    Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29030372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue engineering of a differentiated cardiac muscle construct.
    Zimmermann WH; Schneiderbanger K; Schubert P; Didié M; Münzel F; Heubach JF; Kostin S; Neuhuber WL; Eschenhagen T
    Circ Res; 2002 Feb; 90(2):223-30. PubMed ID: 11834716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogenic properties of the N-terminal region of cardiac myosin binding protein-C in vitro.
    Govindan S; Sarkey J; Ji X; Sundaresan NR; Gupta MP; de Tombe PP; Sadayappan S
    J Muscle Res Cell Motil; 2012 May; 33(1):17-30. PubMed ID: 22527638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered heart tissue graft derived from somatic cell nuclear transferred embryonic stem cells improve myocardial performance in infarcted rat heart.
    Lü S; Li Y; Gao S; Liu S; Wang H; He W; Zhou J; Liu Z; Zhang Y; Lin Q; Duan C; Yang XJ; Wang C
    J Cell Mol Med; 2010 Dec; 14(12):2771-9. PubMed ID: 20586830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Engineered Heart Tissue: Analysis of Contractile Force.
    Mannhardt I; Breckwoldt K; Letuffe-Brenière D; Schaaf S; Schulz H; Neuber C; Benzin A; Werner T; Eder A; Schulze T; Klampe B; Christ T; Hirt MN; Huebner N; Moretti A; Eschenhagen T; Hansen A
    Stem Cell Reports; 2016 Jul; 7(1):29-42. PubMed ID: 27211213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal differentiation, advanced organotypic maturation, and modeling of hypertrophic growth in engineered heart tissue.
    Tiburcy M; Didié M; Boy O; Christalla P; Döker S; Naito H; Karikkineth BC; El-Armouche A; Grimm M; Nose M; Eschenhagen T; Zieseniss A; Katschinksi DM; Hamdani N; Linke WA; Yin X; Mayr M; Zimmermann WH
    Circ Res; 2011 Oct; 109(10):1105-14. PubMed ID: 21921264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miniaturized engineered heart tissues from hiPSC-derived triple cell type co-cultures to study human cardiac function.
    Windt LM; Wiendels M; Dostanić M; Bellin M; Sarro PM; Mastrangeli M; Mummery CL; van Meer BJ
    Biochem Biophys Res Commun; 2023 Nov; 681():200-211. PubMed ID: 37783118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive stretch enhances growth and maturation of 3D stem-cell-derived myocardium.
    Lu K; Seidel T; Cao-Ehlker X; Dorn T; Batcha AMN; Schneider CM; Semmler M; Volk T; Moretti A; Dendorfer A; Tomasi R
    Theranostics; 2021; 11(13):6138-6153. PubMed ID: 33995650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular effects of the myosin activator omecamtiv mecarbil on contractile properties of skinned myocardium lacking cardiac myosin binding protein-C.
    Mamidi R; Gresham KS; Li A; dos Remedios CG; Stelzer JE
    J Mol Cell Cardiol; 2015 Aug; 85():262-72. PubMed ID: 26100051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.